Mental Health Europe statement calling for sunshine
21.10.13
Through our codes of conduct we have established well-managed and thought-out framework for our interactions with HCP’s and HCO’s – who we work with on a regular basis to help ensure the best outcomes for patients. An open exchange of information between pharmaceutical companies and healthcare providers and organisations provides huge added value: Companies can provide information on the latest treatments, while they can also gather feedback from physicians on first-hand experiences of medicines as experienced by patients and how they think treatment can be enhanced. This is invaluable to improving patient outcomes. But it needs to be transparent.
In the time ahead, our companies will work on ensuring that a user-friendly and comprehensive information-sharing system is implemented. The EFPIA Code requires each member company to document and disclose on a publicly accessible website:
